Laura Damme is VP, Clinical Affairs of TransMedics Group, Inc.. Currently has a direct ownership of 5,685 shares of TMDX, which is worth approximately $346,898. The most recent transaction as insider was on Feb 20, 2023, when has been sold 5,685 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.69K
0% 3M change
0% 12M change
Total Value Held $346,898

LAURA DAMME Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2023
BUY
Grant, award, or other acquisition
-
5,685 Added 50.0%
5,685 Common Stock
Dec 15 2022
SELL
Open market or private sale
$296,855 $59.49 p/Share
4,990 Reduced 100.0%
0 Common Stock
Dec 15 2022
BUY
Exercise of conversion of derivative security
$191,915 $38.46 p/Share
4,990 Added 51.28%
4,740 Common Stock
Dec 14 2022
SELL
Open market or private sale
$371,271 $62.43 p/Share
5,947 Reduced 100.0%
0 Common Stock
Dec 14 2022
BUY
Exercise of conversion of derivative security
$228,721 $38.46 p/Share
5,947 Added 50.0%
5,947 Common Stock
LD

Laura Damme

VP, Clinical Affairs
Andover, MA

Track Institutional and Insider Activities on TMDX

Follow TransMedics Group, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMDX shares.

Notify only if

Insider Trading

Get notified when an Trans Medics Group, Inc. insider buys or sells TMDX shares.

Notify only if

News

Receive news related to TransMedics Group, Inc.

Track Activities on TMDX